New prenatal screening test is easier but raises ethical issues
November 8, 2011 By Carolyn Pennington in Health
Judy Delach, cytogenetics supervisor, and Peter Benn in the Human Genetics Cytogenetics Lab. Credit: Carolyn Pennington/UConn Health Center Photo
(Medical Xpress) -- New technology and innovations in genetic sequencing are dramatically changing the field of prenatal diagnosis and testing. Peter Benn, professor and director of the Diagnostic Human Genetics Laboratories at the Health Center, is at the forefront of researching and monitoring those changes and is known as an international expert on the topic.
The most recent and controversial changes involve a new test to screen for Down syndrome. The non-invasive procedure could make prenatal testing easier, but it comes with ethical issues and practical problems associated with providing the new test. Thats where Benn, with more than 30 years experience in the field, offers an important voice to the issue.
Benn is chair of an International Society for Prenatal Diagnosis (ISPD) committee that recommends caution and counseling before women receive the test.
The new test is called MaterniT21 and is now available in major health facilities around the country. All it requires is a small sample of the mothers blood. Through a complex form of DNA sequencing, the test can detect a large proportion of Down syndrome-affected pregnancies. A study published in the journal Genetics in Medicine indicates a Down syndrome detection rate of 98.6 percent.
Up until now, women had to undergo potentially risky procedures called amniocentesis or chorionic villus sampling to detect genetic abnormalities. These invasive tests require tapping into the mothers womb with a needle and carry a small risk of miscarriage.
Benn says ISPD recognizes that the development of the new test will offer substantial opportunities to improve screening. But for now, the committee recommends caution against the ad-hoc use of the test in women at lower risk of Down syndrome-affected pregnancies.
For women who are found to be at high risk using one of the currently accepted prenatal screening protocols, Benn recommends detailed genetic counseling to explain the benefits and limitations of the new test.
Gender Issues
The development of other easier and earlier prenatal screening methods also raise serious concerns about non-medical uses. For example, fetal sex identification for the purpose of gender selection.
Benn and colleagues at the Health Center, bioethicist Audrey Chapman and maternal-fetal medicine expert Dr. James Egan, worked together on a study to determine whether there is gender selection based on ultrasound results.
Their findings, published in the journal Prenatal Diagnosis, found that Asian-American mothers, especially with third pregnancies, had more boys than girls in ratios strongly suggesting prenatal sex selection, similar to that which occurs in China and India.
New screening tests have been developed that allow parents to find out their childs sex even earlier than with ultrasound. Benn wonders whether that may lead to an even greater gender imbalance in countries such as China and India.
Some fetal DNA test-manufacturers are trying to discourage sex selection by not selling in China and India, and requiring customers to sign waivers saying that is not their motivation.
But the simplicity of the testing may make it tough to regulate. If you can send off a blood sample to a laboratory and find out the sex of the baby and go somewhere else to request a pregnancy termination no one will ask why, explains Benn.
Rocket Scientist or Rock Star?
While the new MaterniT21 test is currently aimed at testing for Down syndrome, the technology is in place to identify many more conditions. That means an enormous amount of information will be available about an unborn baby. Just think of the implications, adds Benn.
If testing for mild or late-onset genetic conditions becomes a routine part of prenatal exams, parents will then have to make the difficult decision of whether to carry the unhealthy fetus to term.
But it goes beyond genetic abnormalities or gender, its everything. What would you like to know about your baby sports ability, physical appearance, intelligence? And what if your baby doesnt have the characteristics you had hoped for?
As the technology has developed, there are these really big ethical issues that are emerging and most clinicians are not ready to deal with them, says Benn. Part of my interest has been to draw attention to these ethical issues and in having a discussion about what is the right way to use the new technology.
Provided by
University of Connecticut
-
Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use
Oct 17, 2011 |
not rated yet |
0
-
Boy or girl? A simple test raises ethical concerns
Aug 10, 2011 |
not rated yet |
0
-
DNA blood test can cut invasive testing for Down's syndrome by 98 percent
Jan 11, 2011 |
not rated yet |
0
-
Prenatal biochemical screening only detects half of chromosomal abnormalities
Jun 02, 2008 |
not rated yet |
0
-
Opinions about prenatal screening invisible
Dec 14, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Life expectancy gap widens between those with mental illness and general population
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Health
8 hours ago |
not rated yet |
0
Failure to use linked health records may lead to biased disease estimates
Failure to use linked electronic health records may lead to biased estimates of heart attack incidence and outcome, warn researchers in a paper published in BMJ today.
Health
8 hours ago |
5 / 5 (1) |
0
Dietary advice on added sugar is damaging our health, warns heart expert
Dietary advice on added sugar is damaging our health, warns a cardiologist in BMJ today. Dr. Aseem Malhotra believes that "not only has this advice been manipulated by the food industry for profit but it is actually a risk ...
Health
8 hours ago |
5 / 5 (4) |
0
CDC presents recent trends in health behaviors of US adults
(HealthDay)—In 2008 to 2010, the prevalence of key health behaviors among U.S. adults varied, with about one in five adults current smokers and 62.1 percent overweight or obese, according to a report presented ...
Health
10 hours ago |
5 / 5 (1) |
0
Americans still making unhealthy choices, CDC reports
(HealthDay)—The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or ...
Health
10 hours ago |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.